Revumenib in Patients With Myelofibrosis

NCT07734077 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Myelofibrosis
Post-polycythemia Vera Myelofibrosis
Post-essential Thrombocythemia Myelofibrosis

Interventions

DRUG: Revumenib
DRUG: Ruxolitinib
DRUG: FEDRATINIB
DRUG: Momelotinib

Sponsor

John Mascarenhas

Collaborators

[object Object]
[object Object]